Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Prostate cancer

Alcohol, cancer and 5α-reductase inhibitors—is there a link?


Two major trials have been performed to determine the effect of 5α-reductase inhibitors on subsequent diagnoses of prostate cancer. Both trials showed that high alcohol intake significantly increased prostate cancer risk among men allocated to the treatment arms. The recommendation that patients eliminate alcohol when taking 5α-reductase inhibitors seems appropriate.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. Fowke, J. H., Howard, L., Andriole, G. L. & Freedland, S. J. Alcohol intake increases high-grade prostate cancer risk among men taking dutasteride in the REDUCE trial. Eur. Urol.

  2. Andriole, G. L. et al. Effect of dutasteride on the risk of prostate cancer. N. Engl. J. Med. 362, 1192–1202 (2010).

    Article  CAS  Google Scholar 

  3. Jin, M. et al. Alcohol drinking and all cancer mortality: a meta-analysis. Ann. Oncol. 24, 807–816 (2013).

    Article  CAS  Google Scholar 

  4. Thompson, I. M. et al. The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 349, 213–222 (2003).

    Article  Google Scholar 

  5. Gong, Z. et al. Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer 115, 3661–3669 (2009).

    Article  CAS  Google Scholar 

  6. Mukamal, K. J. Overview of the risks and benefits of alcohol consumption. UpToDate [online], (2014).

    Google Scholar 

  7. Freedland, S. J. et al. Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study. Prostate Cancer Prostatic Dis. 16, 254–259 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Leonard G. Gomella.

Ethics declarations

Competing interests

The author declares that he is a past steering committee member on the REDUCE trial.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gomella, L. Alcohol, cancer and 5α-reductase inhibitors—is there a link?. Nat Rev Urol 11, 253–254 (2014).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing